Xeris Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XERS and other ETFs, options, and stocks.

About XERS

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. 

CEO
John Patrick Shannon
CEOJohn Patrick Shannon
Employees
394
Employees394
Headquarters
Chicago, Illinois
HeadquartersChicago, Illinois
Founded
2005
Founded2005
Employees
394
Employees394

XERS Key Statistics

Market cap
762.34M
Market cap762.34M
Price-Earnings ratio
-15.75
Price-Earnings ratio-15.75
Dividend yield
Dividend yield
Average volume
2.14M
Average volume2.14M
High today
$4.84
High today$4.84
Low today
$4.70
Low today$4.70
Open price
$4.73
Open price$4.73
Volume
1.08M
Volume1.08M
52 Week high
$6.07
52 Week high$6.07
52 Week low
$2.05
52 Week low$2.05

People also own

Based on the portfolios of people who own XERS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.